Last Updated: June 25, 2026

OTICAIR Drug Patent Profile

Name: OTICAIR Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Oticair, and what generic alternatives are available?

Oticair is a drug marketed by Bausch And Lomb and Pharmafair and is included in two NDAs.

The generic ingredient in OTICAIR is hydrocortisone; neomycin sulfate; polymyxin b sulfate. There are sixty-seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the hydrocortisone; neomycin sulfate; polymyxin b sulfate profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for OTICAIR?
What are the global sales for OTICAIR?
What is Average Wholesale Price for OTICAIR?

Summary for OTICAIR

US Patents:	0
Applicants:	2
NDAs:	2
Finished Product Suppliers / Packagers:	5
Raw Ingredient (Bulk) Api Vendors:	2
Patent Applications:	8
DailyMed Link:	OTICAIR at DailyMed

Drug patent expirations by year for OTICAIR

Pharmacology for OTICAIR

Drug Class	Aminoglycoside Antibacterial Corticosteroid Polymyxin-class Antibacterial
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

US Patents and Regulatory Information for OTICAIR

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch And Lomb	OTICAIR	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SUSPENSION/DROPS;OTIC	064065-001	Aug 28, 1996	AT	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Pharmafair	OTICAIR	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SUSPENSION/DROPS;OTIC	062399-001	Nov 18, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.